David T. Ting

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Dynamic monitoring of antibody drug conjugates targeting TROP2 or HER2 in breast cancer using circulating tumor cells

  Proceedings of the National Academy of Sciences · 2026-06-17

• A single-arm, phase II study of ivonescimab in combination with FOLFOX in advanced HER2-negative gastroesophageal adenocarcinomas.

  Journal of Clinical Oncology · 2026-05-28

• A phase II study of FOLFIRINOX (FFX) combined with the glycogen synthase kinase-3beta (GSK-3β) inhibitor elraglusib (ELRA) and the transforming growth factor beta (TGFβ) inhibitor losartan (LOS) in patients with untreated metastatic pancreatic ductal adenocarcinoma (mPDAC).

  Journal of Clinical Oncology · 2026-05-27

• Therapeutic Targeting of Epithelial–Mesenchymal Cellular Plasticity in Pancreatic Cancer

  Clinical Cancer Research · 2025-12-09

• Figure 1 FS1 from FGFR mRNA Expression in Cholangiocarcinoma and Its Correlation with <i>FGFR2</i> Fusion Status and Immune Signatures

  2025-11-25

• Data from Differential Kinase Activity Across Prostate Tumor Compartments Defines Sensitivity to Target Inhibition

  2025-11-24

• Supplementary Data from Differential Kinase Activity Across Prostate Tumor Compartments Defines Sensitivity to Target Inhibition

  2025-11-24

• Claudin 18.2 as a Biomarker for Imaging and Radiopharmaceutical Therapy in Gastric and Pancreatic Tumors

  Journal of Nuclear Medicine · 2025-11-20 · 1 citations

• Neoadjuvant ablative radiation plus immune therapy favorably remodels the hepatocellular carcinoma tumor microenvironmentPreprint

  medRxiv · 2025-11-06

• 665 TROP2 remodeling of the immune microenvironment in triple negative breast cancer

  Regular and Young Investigator Award Abstracts · 2025-11-01

• A TROP2/Claudin program mediates immune exclusion to impede checkpoint blockade in breast cancer 2059

  The Journal of Immunology · 2025-11-01

• Genome‐wide association analysis identifies fucosyltransferase 2 variants associated with pancreatic intraductal papillary mucinous neoplasms

  Cancer · 2025-10-08

• Supplementary Methods and Figures from Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial–Mesenchymal Transition and Inflammation in Cancer Cells in Pancreatic Ductal AdenocarcinomaPreprint

  2025-10-06

• Supplemental Table 3: Pattern 7 Ordered Genes from Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial–Mesenchymal Transition and Inflammation in Cancer Cells in Pancreatic Ductal AdenocarcinomaPreprint

  2025-10-06

• Supplemental Table 2: Pattern 1 Pathways from Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial–Mesenchymal Transition and Inflammation in Cancer Cells in Pancreatic Ductal AdenocarcinomaPreprint

  2025-10-06

• Supplemental Table 1: Pancreas Gene Markers from Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial–Mesenchymal Transition and Inflammation in Cancer Cells in Pancreatic Ductal AdenocarcinomaPreprint

  2025-10-06

• Abstract B117: Intraductal Papillary Mucinous Neoplasm Cellular Plasticity Linked with Repeat Element Dysregulation

  Cancer Research · 2025-09-28

• Abstract B120: Mapping and modulating epithelial-mesenchymal plasticity under RAS(ON) multi-selective inhibition in PDAC through lineage tracing and Perturb-seq

  Cancer Research · 2025-09-28

• Durotaxis is a driver and potential therapeutic target in lung fibrosis and metastatic pancreatic cancer

  Nature Cell Biology · 2025-09-01 · 16 citations

• The Pdgfd-Pdgfrb axis orchestrates tumor-nerve crosstalk in pancreatic cancerPreprint

  bioRxiv (Cold Spring Harbor Laboratory) · 2025-08-31